Hyperbaric Oxygen for Autism Spectrum Disorders: A randomized controlled study

Hyperbaric Oxygen for Autism Spectrum Disorders: A randomized controlled study - hyperbaric oxygen for autism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022025

Enrollment

Registered

2016-05-01

Start date

2016-04-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism spectrum disorder

Interventions

HBOT group (I) Placebo control group (II)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The present study included Egyptian children with ASD participated in this study. All patients were recruited from the neuropediatric clinics Assiut university hospitals and 5 private centers for autism in Upper Egypt.

Exclusion criteria

Exclusion criteria: Subjects who had associated other genetic diseases, autoimmune disorders, neurological diseases (such as cerebral palsy and tuberous sclerosis) and metabolic disorders (e.g. phenylketonuria)

Design outcomes

Primary

Measure	Time frame
Follow up those children by CARS (version 2) for 1 year. It was measured at the beginning of the study, after 6 m and after one year to compare the effect HBOT on ASD	—

Countries

Africa

Contacts

Public ContactKhaled Saad

Faculty of Medicine - Pediatric Department Assiut University pediatric neurology

khaled.ali@med.au.edu.eg+966599760661

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026